BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Queensland Health
Healthtrust
Cantor Fitzgerald
Boehringer Ingelheim
McKesson
Fuji
Deloitte
Teva
Medtronic

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072928

« Back to Dashboard

NDA 072928 describes LORAZEPAM, which is a drug marketed by Amneal Pharms, Hi-tech Pharma Co, Lupin Ltd, Pharm Assoc, Saptalis Pharms, Akorn, Bedford, Dava Pharms Inc, Hospira, Intl Medication Sys, Sagent Agila Llc, Watson Labs, Watson Labs Inc, West-ward Pharms Int, Roxane, Am Therap, Anda Repository, Ani Pharms Inc, Halsey, Leading Pharma Llc, Mutual Pharm, Mylan, Par Pharm, Sandoz, Sun Pharm Inds Ltd, Superpharm, Usl Pharma, Vintage Pharms, Warner Chilcott, and Bedford Labs, and is included in sixty-seven NDAs. It is available from fifty-two suppliers. Additional details are available on the LORAZEPAM profile page.

The generic ingredient in LORAZEPAM is lorazepam. There are eleven drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
Summary for 072928
Tradename:LORAZEPAM
Applicant:Watson Labs
Ingredient:lorazepam
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 072928
Ingredient-typeBenzodiazepines
Medical Subject Heading (MeSH) Categories for 072928
Suppliers and Packaging for NDA: 072928
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LORAZEPAM lorazepam TABLET;ORAL 072928 ANDA Actavis Pharma, Inc. 0591-0242 0591-0242-10 1000 TABLET in 1 BOTTLE, PLASTIC (0591-0242-10)
LORAZEPAM lorazepam TABLET;ORAL 072928 ANDA Actavis Pharma, Inc. 0591-0242 0591-0242-01 100 TABLET in 1 BOTTLE, PLASTIC (0591-0242-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Oct 31, 1991TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Accenture
QuintilesIMS
Healthtrust
AstraZeneca
McKesson
Mallinckrodt
Daiichi Sankyo
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot